Mesenchymal stem cells and cell-derived extracellular vesicles protect hippocampal neurons from oxidative stress and synapse damage induced by amyloid-β oligomers

Alzheimer’s disease (AD) is a disabling and highly prevalent neurodegenerative condition, for which there are no effective therapies. Soluble oligomers of the amyloid-β peptide (AβOs) are thought to be proximal neurotoxins involved in early neuronal oxidative stress and synapse damage, ultimately le...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of biological chemistry Vol. 293; no. 6; pp. 1957 - 1975
Main Authors de Godoy, Mariana A., Saraiva, Leonardo M., de Carvalho, Luiza R.P., Vasconcelos-dos-Santos, Andreia, Beiral, Hellen J.V., Ramos, Alane Bernardo, Silva, Livian R. de Paula, Leal, Renata B., Monteiro, Victor H.S., Braga, Carolina V., de Araujo-Silva, Carlla A., Sinis, Leandro C., Bodart-Santos, Victor, Kasai-Brunswick, Tais Hanae, Alcantara, Carolina de Lima, Lima, Ana Paula C.A., da Cunha-e Silva, Narcisa L., Galina, Antonio, Vieyra, Adalberto, De Felice, Fernanda G., Mendez-Otero, Rosalia, Ferreira, Sergio T.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 09.02.2018
American Society for Biochemistry and Molecular Biology
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Alzheimer’s disease (AD) is a disabling and highly prevalent neurodegenerative condition, for which there are no effective therapies. Soluble oligomers of the amyloid-β peptide (AβOs) are thought to be proximal neurotoxins involved in early neuronal oxidative stress and synapse damage, ultimately leading to neurodegeneration and memory impairment in AD. The aim of the current study was to evaluate the neuroprotective potential of mesenchymal stem cells (MSCs) against the deleterious impact of AβOs on hippocampal neurons. To this end, we established transwell cocultures of rat hippocampal neurons and MSCs. We show that MSCs and MSC-derived extracellular vesicles protect neurons against AβO-induced oxidative stress and synapse damage, revealed by loss of pre- and postsynaptic markers. Protection by MSCs entails three complementary mechanisms: 1) internalization and degradation of AβOs; 2) release of extracellular vesicles containing active catalase; and 3) selective secretion of interleukin-6, interleukin-10, and vascular endothelial growth factor to the medium. Results support the notion that MSCs may represent a promising alternative for cell-based therapies in AD.
Bibliography:Senior authors.
Both authors contributed equally to this work.
Edited by Paul E. Fraser
ISSN:0021-9258
1083-351X
DOI:10.1074/jbc.M117.807180